Pmd176 - Medication Adherence Ascertained by a Digital Observational Study Approach Using a Medical App: A Pilot Study Among Patients With Multiple Sclerosis Treated With Interferon Beta-1b

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1625
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

A Descriptive Study of a Pharmacist Medication Adherence Program for Patients With Multiple Sclerosis Using Interferon Beta

Journal of Pharmacy Practice and Research
PharmacologyPharmacy
2017English

T-Cell Interferon Gamma Receptor Binding in Interferon Beta-1b–Treated Patients With Multiple Sclerosis

Archives of Neurology
1999English

Autoimmune Hypothyroidism Associated With Interferon Beta-1b Treatment in Two Patients With Multiple Sclerosis

Australian and New Zealand Journal of Medicine
2000English

Facilitating Medication Adherence in Patients With Multiple Sclerosis

International Journal of MS Care
NeurologySpecialized NursingAdvanced
2013English

Pulmonary Arterial Hypertension in a Patient With Multiple Sclerosis Treated With Interferon Beta: A Case Report

Journal of Neurology and Neuroscience
2016English

Serum S100B in Primary Progressive Multiple Sclerosis Patients Treated With Interferon-Beta-1a

Journal of Negative Results in BioMedicine
GeneticsPharmacologyMolecular BiologyBiochemistryMedicineToxicologyPharmaceutics
2004English

Masitinib Treatment in Patients With Progressive Multiple Sclerosis: A Randomized Pilot Study

BMC Neurology
MedicineNeurology
2012English

Effects of Whole-Body Vibration in Patients With Multiple Sclerosis: A Pilot Study

Clinical Rehabilitation
Physical TherapySports TherapyRehabilitation
2005English

Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated With Interferon Beta 1a by 1h-NMR Spectroscopy

Neurotherapeutics
NeurologyPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy